Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtech Start-Ups Face Funding Challenges Ahead

Executive Summary

The worldwide recession, uncertainty over US health care reform, and coming changes in the regulatory environment have conspired to limit funding for medical device start-up companies. Investor enthusiasm has been driven down and venture capital markets, which have historically served as the lifeblood of medical device innovation, have been deeply cut, with signs of further contraction as some VCs close their doors. The sector finds itself in, at best, a holding pattern as executives scramble for new sources of operating cash. Medtech reports from the recent Advamed and IN3 conferences.

You may also be interested in...



Venture Capitalists Advise Device Companies to Run Lean

Venture capitalists speaking at the Medtech Insight IN3 Medical Device Summit in San Francisco in October stressed that they need to know how much capital a company will need to break even or turn a profit.

Device Companies Look Far and Wide for New Capital

The global recession that struck last September drove many device investors into hiding. This left a barren financial landscape for device companies to subsist on. But some are finding the funds they need, and they're sharing their survival stories.

Value Proposition Is Key to New Product Success in a Cost-Conscious Medtech Market

The need for a positive economic argument when introducing a new medtech product is more critical than ever. Management teams are well aware of the need to demonstrate compelling economic data, but can a product still be successful without an economic benefit in the increasingly cost-conscious health care marketplace? Overcoming negative economics means identifying a combination of positive attributes that can overcome the economic barrier, and this thought process should be conducted well before significant R&D funds are invested.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

MT035229

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel